RxDoctor Payments Data

John Foster, MD

Family Medicine · Plantation, FLNPI 1457469785

Payments from drug & device makers

$1,564in general payments, 2019–2025

Across 87 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$277
  • Kowa Pharmaceuticals America, Inc.$254
  • Sanofi-aventis U.S. LLC$182
  • Johnson & Johnson$170
  • AstraZeneca$127
  • Amarin Pharma, Inc.$92
  • plus $463 from 15 others

What the payments were for

  • Food & beverage$1,564100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,564 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$214,381
Medicare patients
374
Services billed
2,486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide80$101,153
EliquisApixaban66$40,853
FarxigaDapagliflozin Propanediol26$32,561
XareltoRivaroxaban15$19,582
JardianceEmpagliflozin18$19,271
Tresiba Flextouch U-200Insulin Degludec22$15,534
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$10,623
Tresiba Flextouch U-100Insulin Degludec13$5,633
Rosuvastatin Calcium389$4,746
Omeprazole251$3,687
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,276
Amlodipine Besylate384$2,664
Atorvastatin Calcium283$2,631
Wixela InhubFluticasone Propion/Salmeterol15$2,413
Escitalopram Oxalate117$2,086

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$277$101,15380 claims
PfizerEliquis, Paxlovid$73$42,28281 claims
AstraZenecaFarxiga$127$32,56126 claims
Johnson & JohnsonXarelto$170$19,58215 claims
Boehringer IngelheimJardiance$19$19,27118 claims
GSKTrelegy Ellipta$11$10,62314 claims
AbbVieSynthroid$91$1,86225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Plantation

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →